(PharmaNewsWire.Com, July 24, 2020 ) The study involved two major activities in estimating the current size of the protein crystallization and crystallography market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research.
How the Market Growth looks like and Industry Segmentation?
The Global Protein Crystallization and Crystallography Market size is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.
On the basis of product and service, the consumables segment accounted for the largest share of the protein crystallization and crystallography market in 2019. This can be attributed to a large number of reagent kits and microplates used in proteomics research and the increasing demand for miniature screening plates in automated liquid handlers.
The pharmaceutical companies segment accounted for the largest share of the protein crystallization and crystallography market in 2019. This can be attributed to the increasing demand for protein-based drugs and the increasing demand for biologics in various application areas.
- In 2020, Calibre Scientific (US) acquired NeXtal Biotechnologies (Product Line of QIAGEN) (Netherlands) to strengthen its portfolio of structural biology solutions.
- In 2019, Charles River Laboratories (US) collaborated with CHDI Foundation (US) for the drug discovery and development of therapies for Huntington’s disease.
- In 2018, Bruker Corporation launched a new product, D8 DISCOVER Plus X-ray Diffraction (XRD).
Protein Crystallization & Crystallography Market and Top technologies:
X-ray crystallography -
XRC is a widely used technology for protein analysis and provides data on protein structures at the atomic level, which serves to provide a greater understanding of protein function in terms of their interaction with other molecules, the ability to undergo conformational changes and to perform catalysis in the presence of enzymes. The components used during X-ray crystallographic analysis include protein crystals, X-ray generators, and electronic X-ray detectors.
NMR Spectroscopy -
NMR spectroscopy is a complementary technology to X-ray crystallography, used to determine a protein structure. In contrast to X-ray crystallography, NMR spectroscopy uses proteins in soluble forms.
The protein crystallization and crystallography market is divided into five major regions, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the global market, followed by Europe. The growth in this market can be attributed to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, and the rising demand for high-quality research tools.
Key Market Players
The major companies in the protein crystallization and crystallography market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
